Cannabis Law Report

FEBRUARY 2, 2022

The double-blind, randomised, placebo-controlled clinical trial took place over two years between 2017 and 2019 at the Center for Medicinal Cannabis Research at the University of California. As many patients use cannabis-based medicines to aid with sleep, the current detection window is of significant concern. hours after smoking.

Medicine 52

Medicine Clinical Trials Consumption Sleep 52

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

Sensi Seeds

JANUARY 4, 2019

Context of the Medicinal Cannabis Situation. Under the regulations, no intermediaries are allowed to sell medicinal cannabis to patients. The Canadian medicinal cannabis regime was established in the context of illegal cannabis use. It allows patients to have access to medicinal cannabis without danger of being criminalized.

Medicine 75

Medicine Research and Development Patients Programs 75

Medicinal Marijuana Association

FEBRUARY 10, 2024

With over 100 known cannabinoids in cannabis, staying informed about the latest research is crucial for making informed decisions. However, by following a strategic guide, you can stay ahead of the curve and make informed choices regarding cannabis use.

Research and Development 52

Research and Development Data Chronic Pain Conditions 52

Cannabis Law Report

SEPTEMBER 29, 2021

The Cannabinoid Institute ?(TCI) The data revealed that clinicians who had never experienced cannabis firsthand viewed it much more negatively and stigmatized, whereas clinicians who had experience firsthand with cannabis understood the potential medical benefit for some clinical conditions,” noted Jan Roberts , Founder of TCI. “Our

Cannabinoids 52

Cannabinoids Education Patients Safety 52

Veriheal

FEBRUARY 21, 2023

As medicinal and recreational cannabis legalization continues to sweep across the United States, a recent study paints a concerning portrait of many states denying or restricting medical marijuana (MMJ) access. Furthermore, Nugg MD’s data shows just how vital MMJ access has become in modern society’s health landscape.

Access 98

Access Patients Chronic Pain Conditions 98

Veriheal

AUGUST 15, 2022

Highly rated by users, the Releaf App features an electronic diary that can be updated with information pertaining to self-monitored cannabis session-specific effects. Data was pulled from 3,922 cannabis self-administration sessions with the help of this application. Minor Cannabinoids vs. CBD and THC.

Treatment 96

Treatment Research and Development Sativa Cannabinoids 96

Cannabis Law Report

SEPTEMBER 22, 2021

Data indicates potential of drug candidate to deliver an extremely potent therapeutic benefit at a very low non-toxic dose. New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Data CBD Clinical Trials 52

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Therefore, the growing marijuana market lacks the clinical data needed to help marijuana businesses create new and better products.

Data 45

Data Research and Development Marijuana Collective 45

Veriheal

JUNE 1, 2023

The research authors revealed that hemp seed cake, a by-product from hemp oil extraction, contained low cannabinoids, a healthy source of fiber, and crude protein for cattle and other animals. But regulators are unyielding, expressing skepticism that, if allowed, end consumers may risk exposure to unsafe levels of cannabinoid-laced meat.

THC 97

THC Hemp CBD Supply Chain 97

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. None of the participants had been using any cannabinoid-based products prior to this study.

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98

The Cannigma

FEBRUARY 2, 2021

As medicinal cannabis treatments are now legal in many parts of the world, naturally, there is a growing interest in whether the products can treat neurological conditions like Parkinson’s disease. More than 8 percent of those surveyed also reported already using cannabinoids, with 54 percent noting a beneficial clinical effect.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Cannabis Law Report

JULY 8, 2022

“Individual, licensed laboratories use different methods which may produce inconsistent results and inaccurate data on cannabis cannabinoid content. DCC is working to change that so there is greater integrity in the market, accurate information for consumers, and confidence among stakeholders.”. 1, 2022, from 9 a.m.

Cannabinoids 59

Cannabinoids Safety Packaging Cannabis 59

Veriheal

MAY 26, 2022

But one area of cannabis medicine is still lagging behind—research. Dedicated to “redefining what’s possible,” the 501(c)(3) organization has provided 1:1 support and resources to over 69,000 clients as they navigated plant-powered cannabinoid therapy. Bringing Cannabis Into Mainstream Medicine.

Advocacy 98

Advocacy Patients Clinical Trials Education 98

Cannabis Law Report

AUGUST 10, 2021

GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Alchimia

JANUARY 26, 2016

Spanish Observatory of Medicinal Cannabis. Therefore, users of medicinal cannabis can be completely confident. For this reason, we stress the need for truthful, accurate and scientific information on cannabis and its therapeutic purposes. Cordially, Spanish Observatory of Medicinal Cannabis.

Medicine 48

Medicine Clinical Trials Data Cannabinoids 48

Cannabis Law Report

AUGUST 10, 2021

This acquisition is focused on becoming the first and only company solving the puzzle of chronic pain with MDMA-based medicines utilizing clinical trials for the purposes of novel drug development. Discovering new MDMA medicines and cures for pain management through clinical trials is a game changing opportunity for all our stakeholders.

Chronic Pain 105

Chronic Pain Clinical Trials Research and Development Events 105

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. None of the participants had been using any cannabinoid-based products prior to this study.

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

StrainConnect

APRIL 23, 2019

Why Terpenes Are Vital To Your Cannabinoid Therapy. Remember…were here to make you a more informed consumer, right? 3,4] By observing the terpene profile, cannabinoid presence and potency, and quantity of standard biomolecules like lipids and waxes, scientists can identify different chemovars.

Terpenes 63

Terpenes Cannabinoids Therapy Sativa 63

Cannabis Law Report

JULY 27, 2021

NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, and Biopharmaceutical Research Company (“BRC”), a specialty pharmaceutical company that holds federal licenses for importing, analyzing and manufacturing controlled substances in the U.S.,

Research and Development 98

Research and Development Pharmaceutical Sativa Extraction 98

Veriheal

APRIL 11, 2022

The final goal is to introduce medicinal cannabis products to the pharmaceutical drug market. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website. This means that U.S.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Canna Law Blog

FEBRUARY 25, 2022

Pharmacopeia (USP), which sets standards for medicines, food ingredients and supplements, first documented the use of hemp-derived products in 1850. Exercise enforcement discretion review the safety data of a CBD dietary supplement consistent with the premarket safety review of a new dietary ingredient notification.

CBD 84

CBD Data Safety Food 84

United Patients Group

MAY 17, 2023

Some researchers believe that cannabinoids may help people with ASD manage anxiety and stress by increasing their ability to focus and pay attention. Cannabinoids have been shown to help people with autism manage anxiety and stress. This is called the Entourage Effect.

Sleep 81

Sleep Cannabinoids Patients CBD 81

Cannabis Law Report

JULY 4, 2019

The manuscript is part of EMMAC’s collaboration with Imperial College London, forged to deliver a long-term comprehensive research programme designed to inform and shape the future of the medical cannabis therapeutic industry. About Imperial College London. Imperial College London is one of the world’s leading universities.

Cannabinoids 40

Cannabinoids Clinical Trials Chronic Pain Medicine 40

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. The use of cannabis as a therapeutic and medicinal aid is widely supported.

Consumption 109

Consumption Patients Research and Development Data 109

Veriheal

MAY 18, 2023

Featured in the journal Cannabis and Cannabinoid Research , the guidelines were compiled after researchers perused scientific databases for peer-reviewed English articles on cannabis and pain. Using this information, they composed a list of valuable suggestions for consuming cannabis to treat various types of chronic pain.

Chronic Pain 98

Chronic Pain Treatment Research and Development Patients 98

Puff Puff Post

MARCH 10, 2020

About InMed: InMed Pharmaceuticals is a clinical stage pharmaceutical company developing a pipeline of cannabinoid-based medications, initially focused on the therapeutic benefits of cannabinol (CBN) in diseases with high unmet medical need. For more information, visit www.inmedpharma.com. Visit [link].

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

Cannabis Law Report

MARCH 22, 2020

A data firm is warning those infected with the novel coronoavirus to avoid consuming products that contain tetrahydrocannabinol (THC), the main psychoactive component of cannabis. Data CEO Julie Armstrong said her company knows the COVID-19 affects the population in a similar way to influenza. World Health Organization (WHO).

THC 59

THC Clinical Trials Data Consumption 59

The Cannigma

JULY 1, 2021

The study was developed by People Science , a tech-enabled science company that is focused on connecting “health minded people, research scientists, and healthcare providers in an effort to unlock the potential of alternative medicines,” according to People Science.

Sleep 101

Sleep Edibles Research and Development Data 101

Cannabis Law Report

JULY 13, 2021

Inhalation of cannabis extracts allows for a faster onset and higher bioavailability than tinctures and oils, and now that doctors can monitor a patient’s metered-dosage, more accurate patient data. Patients can now take their medicine without inhaling soot, tar and carcinogens into the lungs.

Extraction 105

Extraction Vaping Medicine Patients 105

Cannabis Law Report

JULY 26, 2021

(VANCOUVER, BC , July 26, 2021)— Trait Biosciences ( [link] ), a leading cannabinoid biotechnology research organization, announced that it has completed a C$31 million (US$25.46 Our mission is to develop the world’s most comprehensive integrated approach to cannabinoid science, insights, and technology. About Trait Biosciences.

Research and Development 98

Research and Development Cannabinoids Environment Banking 98

Veriheal

MAY 30, 2022

Plenty of information exists on how cannabis can be beneficial for humans, but have you ever wondered what the benefits could be for cattle? The researchers from K-State belong to the College of Veterinary Medicine, and they wanted to understand “how hemp can reduce stress and increase the times when cattle lie down.”

Hemp 104

Hemp Cannabinoids Concentrates Agriculture 104

Cannabis Law Report

SEPTEMBER 15, 2021

Delta-8 THC is one of over 100 cannabinoids produced naturally by the cannabis plant but is not found in significant amounts in the cannabis plant. Some concerns include variability in product formulations and product labeling, other cannabinoid and terpene content, and variable delta-8 THC concentrations. synthetic conversion).

THC 105

THC Pets Events Hemp 105

Cannabis Law Report

MAY 18, 2022

Observational Data Collected On Long-term Consumption of Oral C BD Shows No Correlation To Safety Issues Raised by FDA. Still, the FDA has not taken any concrete steps to regulate CBD, claiming that it needs more real-world data to move forward. “We The study abstract is available here. Congress,” said Charlotte’s Web Sr.

Safety 52

Safety Hemp Research and Development Data 52

The Cannigma

JULY 17, 2022

Between internet searches that bring up myths and falsehoods, medical professionals who aren’t properly educated about the plant, and marketing language designed to confuse , it’s easy for someone who is curious about cannabis to get the wrong information. Free cannabis education.

Advocacy 120

Advocacy Education Events Epilepsy 120

Cannabis Law Report

SEPTEMBER 21, 2021

.–(BUSINESS WIRE)– Realm of Caring (RoC) , a nonprofit dedicated to cannabinoid research, has published its latest paper in the medical journal Frontiers in Psychiatry , examining the benefits of medicinal cannabis products for individuals with anxiety and depression. About Realm of Caring.

CBD 52

CBD Data Therapy Sleep 52